The Europe Cancer Diagnostics Market is accounted to reach USD 13.02 billion by 2024 from USD 5.16 billion in 2016, it is growing at a CAGR of 12.3% in the forecast period 2017 to 2024..

The major factors driving the growth of this market are the rise in the aging population in European countries and government initiatives. These factors increase the demand for cancer diagnostic products.

The key market players for Europe Cancer Diagnostics Market are listed below:

• Siemens Healthcare
• Hologic, Inc,
• Becton,
• Dickinson and Company.
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Roche Diagnostics,
• Abbott Laboratories, Inc.,
• QIAGEN.

The market is further segmented into:
• Type
• Application
• Technology
• End User
• Geography

The Europe cancer diagnostics market is segmented on the basis of technology, application and geography. The Europe cancer diagnostics market is segmented into 2 types- platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 67.5% and is expected to continue this trend till 2024.

Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.
Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.
Based on geography, the Europe Cancer Diagnostics Market is segmented into 11 geographical regions, such as,

• Germany,
• France,
• United kingdom,
• Italy,
• Spain,
• Russia,
• Turkey
• , Belgium,
• Netherlands,
• Switzerland,
• Rest of Europe,
Covered in this report
The report covers the present scenario and the growth prospects of the Europe Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.